1Thia KT, Loftus EV Jr, Sandborn WT, et al. An update on theepidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol, 2008,103(12): 3167-3182.
1Ardizzone S, Doldo P, Ranzi T, et al. Mesalazine foam(salofalk foam) in the treatment of active distal ulcerative colitis:acomparative trial vs salofalk enema[J]. Ital J Gastroenterol Hepatol,1999,31(8):677-684.
2Schroeder KW. Role of mesalazine in acute and long-term treatment of ulcerative colitis and its complications[J]. Scand J Gas,2002, 236(Suppl):42-47.
3Gisbert JP, Gomollon F, Mate J, et al. Role of 5-aminosalicylic acid in treatment of inflamematory bowel disease: a systematic review[J]. Dig Dis Sci,2002,47(3):471-488.